Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Colorectal Neoplasms

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 126 articles:
HTML format
Text format



Single Articles


    February 2020
  1. SERRANO PE, Gu CS, Moulton CA, Husien M, et al
    Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    J Surg Oncol. 2020 Feb 7. doi: 10.1002/jso.25864.
    PubMed     Text format     Abstract available


    December 2019
  2. LEIPHRAKPAM PD, Lazenby AJ, Chowdhury S, Smith LM, et al
    Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    J Surg Oncol. 2019 Dec 22. doi: 10.1002/jso.25805.
    PubMed     Text format     Abstract available


  3. LIMA PMA, Torres LC, Martins MR, da Matta MC, et al
    Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
    J Surg Oncol. 2019 Dec 19. doi: 10.1002/jso.25813.
    PubMed     Text format     Abstract available


  4. GOFFREDO P, Zhou P, Ginader T, Hrabe J, et al
    Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.
    J Surg Oncol. 2019 Dec 18. doi: 10.1002/jso.25801.
    PubMed     Text format     Abstract available


  5. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients.
    J Surg Oncol. 2019 Dec 11. doi: 10.1002/jso.25798.
    PubMed     Text format     Abstract available


  6. FIELDS AC, Welten VM, Lu P, Goldberg JE, et al
    Does race impact survival for patients with anal squamous cell carcinoma?
    J Surg Oncol. 2019;120:1201-1207.
    PubMed     Text format     Abstract available


  7. YANG L, Bao J, Jiang Q, Yu DS, et al
    Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
    J Surg Oncol. 2019;120:1184-1189.
    PubMed     Text format     Abstract available


  8. REYNOLDS IS, O'Connell E, Fichtner M, McNamara DA, et al
    Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    J Surg Oncol. 2019;120:1427-1435.
    PubMed     Text format     Abstract available


  9. KIM JC, Lee JL, Kim CW, Lim SB, et al
    Mechanotechnical faults and particular issues of anastomotic complications following robot-assisted anterior resection in 968 rectal cancer patients.
    J Surg Oncol. 2019;120:1436-1445.
    PubMed     Text format     Abstract available


  10. XIAO C, Zhou M, Yang X, Xiao F, et al
    Novel nomogram with microvascular density in the surgical margins can accurately predict the risk for anastomotic leakage after anterior resection for rectal cancer.
    J Surg Oncol. 2019;120:1412-1419.
    PubMed     Text format     Abstract available


    November 2019
  11. SHARMA A, Alatise OI, Adisa AO, Arowolo OA, et al
    Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry.
    J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25768.
    PubMed     Text format     Abstract available


  12. MACARI D, Kawak S, Raofi V, Wasvary H, et al
    Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis.
    J Surg Oncol. 2019 Nov 14. doi: 10.1002/jso.25766.
    PubMed     Text format     Abstract available


  13. GAMBOA AC, Liu Y, Lee RM, Zaidi MY, et al
    A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    J Surg Oncol. 2019;120:932-939.
    PubMed     Text format     Abstract available


  14. CORSINI EM, Mitchell KG, Antonoff MB
    Response to letter to the editor.
    J Surg Oncol. 2019;120:1051-1052.
    PubMed     Text format    


  15. POLI EC, Millis AM, Berger Y, Sherman SK, et al
    Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2019;120:1044-1045.
    PubMed     Text format    


    October 2019
  16. LAPORTE GA, Leguisamo NM, Gloria HCE, Azambuja DB, et al
    The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.
    J Surg Oncol. 2019 Oct 25. doi: 10.1002/jso.25737.
    PubMed     Text format     Abstract available


  17. ROLFF HC, Christensen IJ, Svendsen LB, Wilhelmsen M, et al
    The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
    J Surg Oncol. 2019 Oct 23. doi: 10.1002/jso.25733.
    PubMed     Text format     Abstract available


  18. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Text format     Abstract available


  19. HEALY MA, Thirumurthi S, You YN
    Screening high-risk populations for colon and rectal cancers.
    J Surg Oncol. 2019;120:858-863.
    PubMed     Text format     Abstract available


    September 2019
  20. FIELDS AC, Lu P, Goldberg J, Irani J, et al
    The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
    J Surg Oncol. 2019 Sep 19. doi: 10.1002/jso.25705.
    PubMed     Text format     Abstract available


  21. LEIJSSEN LGJ, Dinaux AM, Kunitake H, Bordeianou LG, et al
    The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer.
    J Surg Oncol. 2019;120:460-472.
    PubMed     Text format     Abstract available


  22. GHIASLOO M, Kahya H, Van Langenhove S, Grammens J, et al
    Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases.
    J Surg Oncol. 2019;120:415-422.
    PubMed     Text format     Abstract available


  23. MAGUIRE LH, Geiger TM, Hardiman KM, Regenbogen SE, et al
    Surgical management of primary colonic lymphoma: Big data for a rare problem.
    J Surg Oncol. 2019;120:431-437.
    PubMed     Text format     Abstract available


  24. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Text format     Abstract available


  25. STUART E, Banerjee S, de la Torre J, Wang Y, et al
    Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    J Surg Oncol. 2019;120:715-721.
    PubMed     Text format     Abstract available


    August 2019
  26. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.
    PubMed     Text format    


  27. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Preventive effects of a synthetic absorbable antiadhesive film (seprafilm) on small bowel obstruction in patients who underwent elective surgery for colon cancer: A randomized controlled trial.
    J Surg Oncol. 2019 Aug 7. doi: 10.1002/jso.25664.
    PubMed     Text format     Abstract available


  28. HUGHES BD, Hancock KJ, Shan Y, Thakker RA, et al
    Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.
    J Surg Oncol. 2019;120:280-286.
    PubMed     Text format     Abstract available


  29. FIELDS AC, Melnitchouk N, Senturk J, Irani J, et al
    Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?
    J Surg Oncol. 2019;120:287-293.
    PubMed     Text format     Abstract available


  30. BAUSYS A, Kuliavas J, Dulskas A, Kryzauskas M, et al
    Early versus standard closure of temporary ileostomy in patients with rectal cancer: A randomized controlled trial.
    J Surg Oncol. 2019;120:294-299.
    PubMed     Text format     Abstract available


  31. HARDIMAN KM, Antunez AG, Kanters A, Schuman AD, et al
    Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer.
    J Surg Oncol. 2019;120:308-315.
    PubMed     Text format     Abstract available


    July 2019
  32. DUMONT F, Munoz MA, De Franco V, Wernert R, et al
    Significance of lymph node involvement in local recurrence of colorectal cancer.
    J Surg Oncol. 2019 Jul 22. doi: 10.1002/jso.25631.
    PubMed     Text format     Abstract available


  33. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Text format     Abstract available


    June 2019
  34. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Text format     Abstract available


  35. LEMOINE L, Thijssen E, Carleer R, Geboers K, et al
    Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial.
    J Surg Oncol. 2019;119:999-1010.
    PubMed     Text format     Abstract available


  36. RAUSA E, Bianco F, Kelly ME, Aiolfi A, et al
    Systemic review and network meta-analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes.
    J Surg Oncol. 2019;119:987-998.
    PubMed     Text format     Abstract available


  37. MESQUITA-NETO JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, et al
    Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
    J Surg Oncol. 2019;119:979-986.
    PubMed     Text format     Abstract available


    May 2019
  38. KIM HS, Kim KM, Lee SB, Kim GR, et al
    Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
    J Surg Oncol. 2019 May 27. doi: 10.1002/jso.25515.
    PubMed     Text format     Abstract available


  39. LORIMER PD, Motz BM, Kirks RC, Han Y, et al
    Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare.
    J Surg Oncol. 2019 May 18. doi: 10.1002/jso.25508.
    PubMed     Text format     Abstract available


    April 2019
  40. LINO-SILVA LS, Anchondo-Nunez P, Chit-Huerta A, Aguilar-Romero E, et al
    Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
    J Surg Oncol. 2019 Apr 24. doi: 10.1002/jso.25482.
    PubMed     Text format     Abstract available


  41. ANTONY P, Harnoss JC, Warschkow R, Schmied BM, et al
    Urgent surgery in colon cancer has no impact on survival.
    J Surg Oncol. 2019 Apr 12. doi: 10.1002/jso.25469.
    PubMed     Text format     Abstract available


  42. LINECKER M, Kuemmerli C, Clavien PA, Petrowsky H, et al
    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.
    J Surg Oncol. 2019;119:604-612.
    PubMed     Text format     Abstract available


  43. KAWAGUCHI Y, Lillemoe HA, Vauthey JN
    Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    J Surg Oncol. 2019;119:594-603.
    PubMed     Text format     Abstract available


  44. KRELL RW, D'Angelica MI
    Treatment sequencing for simultaneous colorectal liver metastases.
    J Surg Oncol. 2019;119:583-593.
    PubMed     Text format     Abstract available


  45. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Text format     Abstract available


  46. DAY RW, Aloia TA
    Enhanced recovery in liver surgery.
    J Surg Oncol. 2019;119:660-666.
    PubMed     Text format     Abstract available


  47. MARGONIS GA, Kreis ME, Wolfgang CL, Weiss MJ, et al
    Mutation status and surgical selection.
    J Surg Oncol. 2019;119:616-622.
    PubMed     Text format     Abstract available


    March 2019
  48. ENG OS, Turaga KK
    Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25438.
    PubMed     Text format     Abstract available


  49. ADVANI S, Kopetz S
    Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25441.
    PubMed     Text format     Abstract available


  50. ALZAHRANI NA, Valle SJ, Fisher OM, Sugarbaker PH, et al
    Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    J Surg Oncol. 2019;119:336-346.
    PubMed     Text format     Abstract available


  51. PENCOVICH N, Houli R, Lubezky N, Goykhman Y, et al
    R1 resection of colorectal liver metastasis - What is the cost of marginal resection?
    J Surg Oncol. 2019;119:347-354.
    PubMed     Text format     Abstract available


  52. CHAPMAN BC, Goodman K, Hosokawa P, Gleisner A, et al
    Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    J Surg Oncol. 2019;119:518-531.
    PubMed     Text format     Abstract available


  53. SCLAFANI F, Hesselberg G, Thompson SR, Truskett P, et al
    Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
    J Surg Oncol. 2019;119:489-496.
    PubMed     Text format     Abstract available


  54. SCHLICK CJR, Merkow RP, Bentrem DJ
    Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    J Surg Oncol. 2019 Mar 1. doi: 10.1002/jso.25423.
    PubMed     Text format     Abstract available


  55. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Response to the Letter to the Editor.
    J Surg Oncol. 2019;119:399.
    PubMed     Text format    


    February 2019
  56. DE ANDRADE JP, Warner SG, Fong Y
    Treatment of metastatic colorectal cancer: innovations in surgical techniques.
    J Surg Oncol. 2019 Feb 27. doi: 10.1002/jso.25418.
    PubMed     Text format     Abstract available


  57. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Text format     Abstract available


  58. MELSTROM LG, Tzeng CD
    Metastatic colorectal cancer: The reality of the present and the optimism of the future.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25427.
    PubMed     Text format    


  59. SANDHU J, Lavingia V, Fakih M
    Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25421.
    PubMed     Text format     Abstract available


  60. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Text format     Abstract available


    January 2019
  61. FLYNN SM, Burchette RJ, Ghassemi M, Ratner O, et al
    Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    J Surg Oncol. 2019 Jan 16. doi: 10.1002/jso.25372.
    PubMed     Text format     Abstract available


  62. LEIJSSEN LGJ, Dinaux AM, Amri R, Taylor MS, et al
    Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25367.
    PubMed     Text format     Abstract available


  63. YU J, Li N, Tang Y, Wang X, et al
    Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
    J Surg Oncol. 2019 Jan 4. doi: 10.1002/jso.25361.
    PubMed     Text format     Abstract available


  64. FIELDS AC, McCarty JC, Ma-Pak L, Lu P, et al
    New lymph node staging for rectal neuroendocrine tumors.
    J Surg Oncol. 2019;119:156-162.
    PubMed     Text format     Abstract available


    December 2018
  65. LINO-SILVA LS, Guzman-Lopez JC, Zepeda-Najar C, Salcedo-Hernandez RA, et al
    Overall survival of patients with colon cancer and a prolonged time to surgery.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25354.
    PubMed     Text format     Abstract available


  66. JIANG Z, Sun L, Yang W, Li J, et al
    Excessive expectations for carcinoembryonic antigen targeted fluorescent-guided surgery for sentinel lymph node detection in colorectal, pancreatic, and gastric cancer.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25318.
    PubMed     Text format    


  67. CHAKEDIS J, Beal EW, Sun S, Galo J, et al
    Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    J Surg Oncol. 2018;118:1065-1073.
    PubMed     Text format     Abstract available


  68. SUAREZ J, Goicoetxea A, Gomez ML, Jimenez G, et al
    Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
    J Surg Oncol. 2018;118:1122-1128.
    PubMed     Text format     Abstract available


  69. REYNOLDS IS, McNamara DA, Kay EW, O'Neill B, et al
    The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    J Surg Oncol. 2018;118:1129-1134.
    PubMed     Text format     Abstract available


    November 2018
  70. MORIS D, Tsilimigras DI, Machairas N, Merath K, et al
    Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25313.
    PubMed     Text format     Abstract available


  71. LIAO CK, Chiang JM, Tsai WS, You JF, et al
    Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    J Surg Oncol. 2018 Nov 8. doi: 10.1002/jso.25270.
    PubMed     Text format     Abstract available


  72. CHOUHAN H, Sammour T, Thomas ML, Moore JW, et al
    The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25275.
    PubMed     Text format     Abstract available


    October 2018
  73. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Text format     Abstract available


    September 2018
  74. WATANABE A, Harimoto N, Araki K, Yoshizumi T, et al
    A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
    PubMed     Text format     Abstract available


  75. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Text format     Abstract available


  76. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Text format     Abstract available


  77. MANCEAU G, Mori A, Bardier A, Augustin J, et al
    Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?
    J Surg Oncol. 2018 Sep 13. doi: 10.1002/jso.25169.
    PubMed     Text format     Abstract available


  78. LI J, Gu J, Ma X, Li X, et al
    Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25213.
    PubMed     Text format     Abstract available


  79. HU WH, Chen HH, Yen SL, Huang HY, et al
    Re: Increased expression of interleukin-23 associated with progression of colorectal cancer. Journal of Surgical Oncology 2017;115(2):208-212.
    J Surg Oncol. 2018;118:723.
    PubMed     Text format    


  80. KERANMU A, Liu HN, Wu YC, Liu TT, et al
    A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.
    J Surg Oncol. 2018;118:536-543.
    PubMed     Text format     Abstract available


  81. TANG Y, Rao S, Yang C, Hu Y, et al
    Value of MRI morphologic features with pT1-2 rectal cancer in determining lymph node metastasis.
    J Surg Oncol. 2018;118:544-550.
    PubMed     Text format     Abstract available


    August 2018
  82. HENTZEN JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, et al
    Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
    J Surg Oncol. 2018;118:332-343.
    PubMed     Text format     Abstract available


    July 2018
  83. KRUGER JAP, Fonseca GM, Makdissi FF, Jeismann VB, et al
    Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras.
    J Surg Oncol. 2018;118:50-60.
    PubMed     Text format     Abstract available


    June 2018
  84. LE SOUDER E, Azin A, Wood T, Hirpara D, et al
    The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25122.
    PubMed     Text format     Abstract available


  85. SIDERAS K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, et al
    Prognostic value of intra-tumoral CD8(+) /FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25091.
    PubMed     Text format     Abstract available


  86. ZAIMI I, Sparreboom CL, Lingsma HF, Doornebosch PG, et al
    The effect of age on anastomotic leakage in colorectal cancer surgery: A population-based study.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25108.
    PubMed     Text format     Abstract available


  87. LI J, Wang Y, Liu D, Zhou H, et al
    Multidimensional analyses of the learning curve for single-incision plus one port laparoscopic surgery for sigmoid colon and upper rectal cancer.
    J Surg Oncol. 2018;117:1386-1393.
    PubMed     Text format     Abstract available


  88. FONSECA GM, de Mello ES, Faraj SF, Kruger JAP, et al
    Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    J Surg Oncol. 2018;117:1364-1375.
    PubMed     Text format     Abstract available


  89. CHO MS, Park YY, Yoon J, Yang SY, et al
    MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
    J Surg Oncol. 2018;117:1823-1832.
    PubMed     Text format     Abstract available


    May 2018
  90. CHOE EK, Yi JW, Chai YJ, Park KJ, et al
    Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25078.
    PubMed     Text format     Abstract available


  91. DUPRE A, Rehman A, Jones RP, Parker A, et al
    Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    J Surg Oncol. 2018;117:1330-1336.
    PubMed     Text format     Abstract available


  92. DINAUX AM, Leijssen LGJ, Bordeianou LG, Kunitake H, et al
    Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes.
    J Surg Oncol. 2018;117:1323-1329.
    PubMed     Text format     Abstract available


    April 2018
  93. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Text format     Abstract available


  94. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    PubMed     Text format     Abstract available


  95. ZHONG A, Tian Y, Zhang H, Lai M, et al
    DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    J Surg Oncol. 2018;117:1029-1037.
    PubMed     Text format     Abstract available


  96. BOGACH J, Tsai S, Zbuk K, Wong R, et al
    Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study.
    J Surg Oncol. 2018;117:1038-1042.
    PubMed     Text format     Abstract available


  97. JUSTINGER C, Gruden J, Kouladouros K, Stravodimos C, et al
    Histopathological changes resulting from selective internal radiotherapy (SIRT).
    J Surg Oncol. 2018;117:1084-1091.
    PubMed     Text format     Abstract available


  98. MCCLUNEY SJ, Giakoustidis A, Segler A, Bissel J, et al
    Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis.
    J Surg Oncol. 2018;117:1058-1065.
    PubMed     Text format     Abstract available


    March 2018
  99. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    PubMed     Text format     Abstract available


  100. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    PubMed     Text format     Abstract available


  101. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    PubMed     Text format     Abstract available


  102. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    PubMed     Text format     Abstract available


  103. CABELLOS OLIVARES M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, et al
    C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
    J Surg Oncol. 2018;117:717-724.
    PubMed     Text format     Abstract available


  104. SUN Y, Zhang Y, Wu X, Lin H, et al
    Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    J Surg Oncol. 2018;117:737-744.
    PubMed     Text format     Abstract available


  105. AMIKURA K, Akagi K, Ogura T, Takahashi A, et al
    The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
    J Surg Oncol. 2018;117:745-755.
    PubMed     Text format     Abstract available


  106. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Text format     Abstract available


  107. PAK LM, Kemeny NE, Capanu M, Chou JF, et al
    Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    J Surg Oncol. 2018;117:634-643.
    PubMed     Text format     Abstract available


  108. IHNAT P, Slivova I, Tulinsky L, Ihnat Rudinska L, et al
    Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study).
    J Surg Oncol. 2018;117:710-716.
    PubMed     Text format     Abstract available


    February 2018
  109. LE SOUDER EB, Azin A, Hirpara DH, Walker R, et al
    Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25020.
    PubMed     Text format     Abstract available


  110. WALKER R, Wood T, LeSouder E, Cleghorn M, et al
    Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival.
    J Surg Oncol. 2018 Feb 23. doi: 10.1002/jso.25009.
    PubMed     Text format     Abstract available


  111. HUIJBERS A, van Pelt GW, Kerr RS, Johnstone EC, et al
    The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.24998.
    PubMed     Text format     Abstract available


  112. IDREES K, Padmanabhan C, Liu E, Guo Y, et al
    Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
    J Surg Oncol. 2018;117:284-289.
    PubMed     Text format     Abstract available


  113. GRAVANTE G, Stephenson JA, Elshaer M, Osman A, et al
    Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    J Surg Oncol. 2018;117:269-274.
    PubMed     Text format     Abstract available


  114. TANI K, Shindoh J, Akamatsu N, Arita J, et al
    Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    J Surg Oncol. 2018;117:191-197.
    PubMed     Text format     Abstract available


    December 2017
  115. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    PubMed     Text format     Abstract available


  116. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    PubMed     Text format     Abstract available


  117. GOTO S, Hida K, Kawada K, Okamura R, et al
    Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
    J Surg Oncol. 2017;116:989-995.
    PubMed     Text format     Abstract available


  118. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    J Surg Oncol. 2017;116:1150-1158.
    PubMed     Text format     Abstract available


  119. AL-NAJAMI I, Drue HC, Steele R, Baatrup G, et al
    Dual energy CT - a possible new method to assess regression of rectal cancers after neoadjuvant treatment.
    J Surg Oncol. 2017;116:984-988.
    PubMed     Text format     Abstract available


    November 2017
  120. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Text format     Abstract available


  121. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Text format     Abstract available


  122. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    PubMed     Text format     Abstract available


    October 2017
  123. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    PubMed     Text format    


  124. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    PubMed     Text format     Abstract available


    September 2017
  125. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    PubMed     Text format     Abstract available


    May 2017
  126. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: